Inherited Retinal Diseases

Latest News

Ocuphire Pharma acquires Opus Genetics
Ocuphire Pharma acquires Opus Genetics

October 22nd 2024

The acquisition creates a clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations.

AAO 2024: Deuterated vitamin A preserves vision in Stargardt disease
AAO 2024: Deuterated vitamin A preserves vision in Stargardt disease

October 20th 2024

AAO 2024: The treatment for Stargardt disease in adolescents
AAO 2024: The treatment for Stargardt disease in adolescents

October 19th 2024

Nanoscope Therapeutics Inc. acquires a license for the CatCh technology
Nanoscope Therapeutics Inc. acquires a license for the CatCh technology

October 13th 2024

Verana Health debuts Qdata Explorer in advance of American Academy of Ophthalmology 2024 Annual Meeting
Verana Health debuts Qdata Explorer in advance of American Academy of Ophthalmology 2024 Annual Meeting

October 11th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.